Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis and haemostasis, and vascular biology.
News Steep rise for Life Sciences and Medicine in QS World University Rankings The College of Medical and Dental Sciences achieves significant rises in subject rankings, according to latest figures.
News Dr Pavlovic appointed as Editor in Chief of the Journal of Molecular and Cellular Cardiology PLUS
QS World University Subject Rankings released for 2023 University of Birmingham rises 30 places to be joint 62nd in the world for Life Sciences and Medicine.
21 September 2021 Kidney donation does not increase the risk of cardiovascular disease for donors, research confirms The study has confirmed that donating a kidney does not have an adverse effect on a donor's cardiovascular system or blood pressure for at least five years.
31 August 2021 Artificial Intelligence approach helps to identify patients with heart failure that respond to beta-blocker treatment Researchers at the University of Birmingham have developed a new way to identify which patients with heart failure will benefit from treatment with beta-blockers.
25 August 2021 Birmingham scientists discover new piece of clotting puzzle In research that provides a new perspective on how blood clotting works in infectious and inflammatory diseases, Birmingham scientists have described a potential new target and strategy for anti-thrombotic therapy.
04 August 2021 New research to find out what damage diabetes does to the smallest blood vessels of the heart in order to develop new therapies Dr Neena Kalia, Reader at the Institute of Cardiovascular Sciences, has been awarded a three-year BHF research grant to find out what damage diabetes does to the smallest blood vessels of the heart.
04 August 2021 New Birmingham-Roche collaboration targets new treatments for inflammatory bowel disease A new £850k collaboration between Birmingham Health Partners and global biotechnology leaders Roche is set to improve both diagnosis and care of patients with inflammatory bowel disease.
13 July 2021 Partnership will create the next generation of researchers to transform global healthcare The Universities of Birmingham, Leicester and Nottingham have launched a partnership training the next generation of leading researchers the skills required to transform our understanding and treatment of disease.
29 June 2021 Launch of the national Congenital Heart Disease Priority Setting Partnership Today, 29 June 2021, sees the launch of the UK's first national study to identify research priorities for children and adults diagnosed with congenital heart disease (CHD).